O

Orbital Therapeutics

67 employees

DEFINING THE FUTURE OF RNA MEDICINES. Orbital Therapeutics is on a mission to enhance global health by unleashing the full potential of RNA medicines to treat human disease in ways that were not previously possible.

Investor insights

Funding rounds participated in

$270M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2022

Funding rounds raised

Total raised

$270M

from 2 investors over 1 rounds

O

Orbital Therapeutics raised $270M on May 26, 2023

Investors: ARCH Venture Partners and + 12 Other investors